Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0060
+0.0010 (20.00%)
At close: Jan 16, 2026

Revenue by Product

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Regenerative Medical Applications
236.56K
Log In
Log In
Log In
Log In
Upgrade
Regenerative Medical Applications Growth
0%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
United States
236.56K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
0%
Log In
Log In
Log In
Log In
Upgrade